Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Immunogen Inc (IMGN)

9.99 -0.13 (-1.28%)

04-24 16:00

Open:

10.1

Pre. Close:

10.12

High:

10.19

Low:

9.74

Volume:

2,399,122

Market Cap:

1327M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

10.194 - 10.263

10.263 - 10.32

Low:

9.611 - 9.677

9.677 - 9.731

Close:

9.892 - 10.001

10.001 - 10.09

Technical analysis  (as of: 2018-04-24 4:25:51 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 14.00     One year: 15.66

Support:

Support1: 9.68    Support2: 8.05

Resistance:

Resistance1: 11.99    Resistance2: 13.41

Pivot:

10.25

Moving Averages:

MA(5): 10.16     MA(20): 10.33

MA(100): 9.16     MA(250): 7.25

MACD:

MACD(12,26): -0.23     Signal(12,26,9): -0.20

%K %D:

%K(14,3): 33.11     %D(3): 34.67

RSI:

RSI(14): 42.83

52-Week:

High: 13.41  Low: 3.73  Change(%): 132.3

Average Vol(K):

3-Month: 337561  10-Days 232114

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
IMGN has closed above bottom band by 22.9%. Bollinger Bands are 49.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to IMGN's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-20T08:00:00-04:00
ImmunoGen Announces Conference Call to Discuss Its First Quarter 2018 Operating Results

2018-04-06T07:14:53-04:00
Key events next week - healthcare

2018-03-29T08:00:00-04:00
3 Things In Biotech, March 28: The Bristol-Myers Expansion, The Heat Bio Rise, The Immunogen Movement

2018-03-27T08:00:00-04:00
Your Daily Pharma Scoop: Flex Pharma Data, Protagonist Setback, ImmunoGen Results

2018-03-26T09:17:21-04:00
Premarket Gainers as of 9:05 am (03/26/2018)

2018-03-26T08:44:52-04:00
ImmunoGen's mirvetuximab soravtansine shows positive effect in Phase 1/2 ovarian cancer study; shares up 12% premarket

2018-03-26T08:32:37-04:00
Premarket analyst action - healthcare

2018-03-26T07:24:30-04:00
Biotech Forum: The Week Ahead

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

132.85

Shares Float (M)

130.46

% Held by Insiders

1.80

% Held by Institutions

79.00

Shares Short (K)

11049

Shares Short Prior Month (K)

12280

Stock Financials

EPS

EPS Est. Current Year

-0.720

EPS Est. Next Year

-1.380

EPS Est. Next Quarter

-0.240

Forward EPS

-0.900

Book Value (p.s.)

63.670

PEG Ratio

Profit Margin

-90.48

Operating Margin

-50.42

Return on Assets (ttm)

-32.6

Return on Equity (ttm)

536.5

Qtrly Rev. Growth

184.9

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

7.64

Levered Free Cash Flow (M)

-23.51

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.16

P/S

1124721536.00

P/CF

173.71

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.